In light of the potential role of plasma HA, CD44 and RHAMM levels as biomarkers for predicting DKD, we conducted an analysis to determine whether these biomolecules and other clinical parameters could function as independent risk factors for eGFR. Here, CD44 is linked to diabetic kidney disease.